Clinical trials
Phase 1 Esophageal Squamous Cell Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 5 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| Peking University | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| Sichuan University | 2 |
| West China Hospital | 2 |
| Affiliated Cancer Hospital of Shantou University Medical College | 1 |
| Allist Pharmaceuticals, Inc. | 1 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 1 |
| Hebei Medical University Fourth Hospital | 1 |
| Hecheng Li M.D., Ph.D | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 22 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Esophageal Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Colorectal Neoplasms | 3 |
| Head and Neck Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Pancreatic Ductal | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.